Caturjata Churna: Benefits, Evidence & Safety

TL;DR: Caturjata Churna is a classical four-herb powder, cinnamon bark, cardamom seeds, tejpatta leaves, and nagakesara flowers, traditionally used for appetite and digestion. In a 2026 randomized trial of 70 postpartum women, its pain relief was comparable to dicyclomine, but the trial was small, unblinded, and studied after-birth pain, not digestion. (60 words. Sources: JETIR, 2026; Journal of Pharmacognosy and Phytochemistry, 2013)

What it is

Caturjata Churna (also spelled Chaturjat Churna) is a classical Ayurvedic polyherbal powder made of four aromatic ingredients combined in equal proportion (1:1:1:1): Tvak, the bark of true cinnamon (Cinnamomum zeylanicum). Ela, the seeds of cardamom (Elettaria cardamomum); Patra, the leaves of tejpatta or Indian bay leaf (Cinnamomum tamala); and Nagakesara, the flowers of Mesua ferrea. The formula is attributed to the Sharangdhara Samhita, Madhyama Khanda 6/14. (Journal of Pharmacognosy and Phytochemistry, 2013)

One published laboratory preparation of the formulation described a different fourth ingredient (Callicarpa macrophylla) than the classical Nagakesara, which shows that what is sold under the name can vary between manufacturers. (International Journal of Pharmacy & Life Sciences, 2011)

Traditional use

Traditional and classical sources describe Caturjata Churna for vata-kapha disorders, poor appetite (aruchi), weak digestion (agnimandya), and hepatic and renal complaints. It is also mentioned in traditional literature for cough, cold, and piles. These are classical Ayurvedic indications: no modern clinical trial has tested the formulation for any of these digestive or other uses. (Journal of Pharmacognosy and Phytochemistry, 2013; International Journal of Pharmacy & Life Sciences, 2011)

What modern research says

The strongest formulation-specific evidence is about product quality, not efficacy. Laboratory standardization studies have compared marketed and in-house preparations of Caturjata Churna using pharmacognostic identification, ash and extractive values, and phytochemical screening, finding the products broadly comparable with some variation attributable to raw-material geography. (Indian Journal of Traditional Knowledge, 2020)

One clinical trial exists. A 2026 randomized, open-label study enrolled 70 postpartum women with after-birth abdominal pain (sutika makalla shula): 35 received Chaturjat Churna 5 g twice daily and 35 received the antispasmodic drug dicyclomine 20 mg, each for 7 days. Both groups improved significantly; reported pain relief was about 60% versus 54%, and average overall improvement 62.69% versus 63.10%: comparable, not superior, results for postpartum pain. The trial was small, single-center, and unblinded, so this is preliminary evidence for one indication only. (JETIR, 2026)

No published human trials have tested Caturjata Churna for digestion, appetite, piles, or its other traditional uses. Standardization studies confirm composition and quality, not clinical effect. (JETIR, 2026; Indian Journal of Traditional Knowledge, 2020)

Dosage

The only published clinical trial used 5 g of Chaturjat Churna twice daily for 7 days in postpartum women with after-birth abdominal pain: a research regimen for one specific indication, not general dosing guidance. (JETIR, 2026)

No government pharmacopoeial dose for general use could be verified, so the trial number above should not be used for self-dosing. Do not extrapolate a postpartum-pain regimen to other conditions or populations.

Safety & contraindications

Safety data are limited. The only human trial studied postpartum (after-delivery) women, excluded complicated deliveries, and reported no detailed adverse-event data, so its safety findings cannot be generalized. (JETIR, 2026) There are no published safety studies of Caturjata Churna during pregnancy itself, in breastfeeding beyond the postpartum trial, or in children: talk to a qualified clinician before use in these situations.

As a pure-herb powder containing no added metals or minerals, it avoids the heavy-metal concerns associated with bhasma (calcined mineral) preparations, but commercial quality varies between manufacturers, as documented by the standardization literature. (Indian Journal of Traditional Knowledge, 2020)

FAQs

What is Caturjata Churna made of?

Caturjata Churna combines four aromatic ingredients in equal parts: Tvak (true cinnamon bark, Cinnamomum zeylanicum), Ela (cardamom seeds, Elettaria cardamomum), Patra (tejpatta leaves, Cinnamomum tamala), and Nagakesara (Mesua ferrea flowers), per its classical formula in Sharangdhara Samhita. Standardization studies confirm this 1:1:1:1 composition. (Journal of Pharmacognosy and Phytochemistry, 2013) (49 words)

What is Caturjata Churna traditionally used for?

Classical and traditional sources describe it for vata-kapha disorders, poor appetite, weak digestion, and hepatic and renal complaints; it is also mentioned for cough, cold, and piles. These are traditional Ayurvedic indications, not findings of modern clinical trials, and no trials have tested them. (Journal of Pharmacognosy and Phytochemistry, 2013) (50 words)

What did the clinical trial of Caturjata Churna find?

A 2026 randomized, open-label trial enrolled 70 postpartum women with after-birth abdominal pain: 35 received Caturjat Churna (5 g twice daily) and 35 received dicyclomine for 7 days. Pain relief was about 60% versus 54%, and overall improvement 63% versus 63%: comparable results. Both groups improved significantly, but the trial was small, single-center, and unblinded. (JETIR, 2026) (58 words)

Is Caturjata Churna proven to help digestion?

No. Although traditional texts describe it for appetite and digestion, there are no published human trials testing those uses. The only clinical trial studied it for postpartum abdominal pain, a completely different indication. Standardization studies confirm the product's quality and composition, but they do not measure efficacy. (JETIR, 2026; Indian Journal of Traditional Knowledge, 2020) (55 words)

How much Caturjata Churna was used in the trial?

The 2026 trial gave 5 grams twice daily for 7 days, with warm water as the vehicle, to postpartum women. That was a research regimen for a specific indication, not general dosing guidance: no government pharmacopoeial dose for general use could be verified, so do not use this number to self-dose. (JETIR, 2026) (54 words)

Is Caturjata Churna safe in pregnancy or breastfeeding?

Direct safety data are limited. The only human trial studied postpartum (after-delivery) women and excluded complicated cases; it reported no detailed adverse-event data. There are no published safety data for use during pregnancy itself or for breastfeeding beyond that trial, so talk to a qualified clinician before use in these situations. (JETIR, 2026) (53 words)

Are there any side effects or quality concerns?

Reported side effects are not documented in the published literature: a genuine evidence gap. As a pure-herb powder it contains no added metals or minerals, but one preparation described a different fourth ingredient than the classical formula, showing that commercial quality varies. Buy from reputable manufacturers and talk to a clinician. (International Journal of Pharmacy & Life Sciences, 2011) (60 words)

Sources

Educational only — this article is for information, not medical advice. Consult a qualified practitioner before using any Ayurvedic formulation.